Fresh filings this week reveal a split market in boardrooms. Insiders are making bold moves on both sides of the ledger.
BSX CEO Michael Mahoney filed this week disclosing a $9M personal purchase. He bought 186,240 shares at roughly $48.33 apiece on August 3. It's a notable open-market bet from a sitting chairman and CEO. Insider confidence at Boston Scientific rarely comes this explicitly.
Across the Atlantic, ACS Chairman and CEO Florentino Perez filed three separate buys totalling over $30M in his own company. The trades ran from August 3–5 at prices around €110. That level of repeated buying in a single week stands out.
On the selling side, JNJ CEO Joaquin Duato filed a $10.8M sale on August 7. He offloaded nearly 42,000 shares at $258 each. SCHW founder Charles Schwab disclosed two sales totalling $15.1M over consecutive days. CVX director John Hess filed three sales worth a combined $25.3M, all executed on August 3.
AGYS CEO Ramesh Srinivasan filed back-to-back sales on August 5 and 6 totalling $14.3M. Two filings in two days from the same executive is a notable cluster worth watching.
ILMN board member Keith Meister filed two sales worth $56.7M combined. He sold on both August 4 and 5, signalling continued exit pressure at Illumina.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
